FDA pharmacologic class
Renal Dehydropeptidase Inhibitor
0 medicines are in FDA's class of renal dehydropeptidase inhibitors: ; 2 combination products also contain one. 1 of the 2 are listed from generic labelers (FDA NDC Directory, October 8, 2026).
Which medicines are renal dehydropeptidase inhibitor?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Cilastatin and imipenem | Primaxin | 2 labelers | n/a | No | A presentation being discontinued | 0 |
| Cilastatin and imipenem and relebactam | Recarbrio | none listed | n/a | No | A presentation being discontinued | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)